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We studied the selectivity of GABAs receptors for coupling to G proteins by testing the ability of various purified G proteins to increase GABA 
binding to N-ethylmaleimide (NEM)-treated membranes of bovine brain. The addition of G,, QI or G,, to NEM-treated membranes increased 
GABA binding in a dose-dependent manner. However. the addition of G, did not elicit a marked increase in GABA binding. When a subunits 
of G proteins were mixed with various brain p/ subunit complexes composed of different 7 subunits, and they were added to the NEM-treated 
membranes, G,, with any p/ subunits hardly increased GABA binding. On the other hand, G, with any 8) subunits caused a marked increase, 
though G, with a small y subunit was more effective than that with a large 7 subunit. These data suggest that the selective coupling of the G proteins 
to GABA” receptors is determined by the z subunit. 
GABA, receptor; GTP-binding protein; N-Ethylmaleimide; Reconstitution 
1. INTRODUCTION 
The GTP-binding proteins (G proteins) comprise a 
family of structurally homologous regulatory proteins 
serving as intermediaries in transmembrane signal 
transduction [l]. G proteins couple cell-surface recep- 
tors to various effecters, such as enzymes generating se- 
cond messengers and ion channels. Among G proteins, 
there are several proteins sensitive to pertussis toxin, 
such as Gi, G, and transducin. Molecular cloning has 
revealed the presence of three forms of Gi subspecies, 
Gil, Gi2 and Gix [ 11, and proteins corresponding to 
these genes have been identified [2-71. Recently, G,*, 
which may represent a novel form of G,, has been 
purified from brain [8]. 
[ 171 have shown that D2 dopamine receptors selectively 
coupled to Giz with about lo-fold higher affinity than 
Gil or Gi3 and did not couple to G,, though the results 
conflicted with the report by Ohara et al. [ 141. Further- 
more, insulin-like growth factor-II receptors interacted 
only with Gi2, but not with Gil or G, [18]. 
To elucidate the functional difference among G pro- 
teins, the selectivity of receptor-G protein coupling and 
of G protein-effector coupling was studied by the use 
of various systems [9]. Interactions between G proteins 
and receptors have been examined using reconstitution 
techniques. Rhodopsin [lo], crz-adrenergic [ 10,111, y- 
opioid [ 121, muscarinic cholinergic [ 131, DZ dopamine 
[ 141 and chemotactic peptide [15] receptors did not ap- 
pear to distinguish particularly well between ‘G,’ and 
‘Gi’ in most cases. In early experiments, however, 
purified ‘G,’ and ‘Gi’ were used which were not strictly 
identified and might be a mixture of multiple 
subspecies. Recently, Haga et al. [16] have shown that 
muscarinic acetylcholine receptors similarly interacted 
with Gil, Gi2 and G,. On the other hand, Senogles et al. 
In our previous studies, we demonstrated the coupl- 
ing between GABAB receptors and G proteins using 
reconstitution techniques, but there was no selectivity 
for the coupling of ‘G,’ and ‘Gi’ to receptors [19,20]. 
Because G, and Gi subspecies could recently be purified 
and identified as mentioned above, we could study the 
selectivity of G proteins for coupling to GABAn recep- 
tors more precisely. In the present study, we compared 
the ability of four G proteins including G,, G,*, Gil and 
Gi2 to couple to GABAn receptors. We also examined 
the effect of two ,&y subunit complexes, which were 
composed of distinct y subunits and recently isolated 
from bovine brain [21], on the coupling to GABAn 
receptors. 
2. MATERIALS AND METHODS 
2.1. Purification of G proteins 
Correspondence address: T. Asano, Department of Biochemistry, In- 
stitute for Developmental Research, Aichi Prefectural Colony, 
Kasugai, Aichi 480-03, Japan 
G,, G,I and G,z were purified from bovine brain or lung by the 
method of Katada et al. [22]. G,t was purified from bovine brain as 
described by Goldsmith et al. [S]. The cy subunits of Go and Gtz were 
purified from bovine brain and lung, respectively, as described 
previously [5,23]. Analysis of the purified G proteins by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) is 
shown in Fig. 1. The fir subunit complexes composed of different y 
subunits were purified from bovine brain by the method of Asano et 
al. [21]. Final preparations of all G proteins were in the medium con- 
taining 20 mM Tris-HCI (pH 8.0). 0.1 mM EDTA, 0.5 mM 
dithiothreitol (DTT), 0.1% Lubrol PX and 0.1 M potassium 
phosphate. Protein in the G protein preparations was assayed by the 
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Fig. 1. SDS-PAGE patterns of purified Ci proteins and N subunits. 
Purified G proteins (1 pg) and LY subunits (0.5 rg) were subjected to 
SDS-PAGE. The gel was stained with Coomassie blue. Lane 1, G,; 
lane 2, Cit; lane 3, G,I; lane 4, brain G,z; lane 5, lung G,z; lane 6, G”LY; 
lane 7, lung G,LN. 
method of Schaffner and Weissman [24]. The binding of GTPyS and 
incorporation of ADP-ribose to purified CJ proteins were in a range 
from 0.5 to 0.9 mol/mol protein. The amounts of C protein in this 
paper were shown in mols quantified by their ability to bind GTPyS. 
2.2. Preparation of N-ethylmaleimide-treated membranes and 
reconstitution with purified G proteins 
The agonist binding to the G protein-coupled receptors shows the 
high affinity only when G proteins bind to receptors. We previously 
showed that treatment of bovine brain membranes with pertussis tox- 
in [19] or N-ethylmaleimide (NEM) [20] caused a loss of the high- 
affinity binding of GABA to GABAs receptors because the ADP- 
ribosylation or alkylation of endogenous G proteins in the mem- 
branes caused uncoupling of G proteins from receptors. The addition 
of the purified ‘G,’ or ‘G,’ to pertussis toxin- or NEM-treated mem- 
branes restored the high-affinity GABA binding. In the present 
study, we used the reconstitution technique as described below. The 
membranes from bovine cerebral cortex were treated with 0.2 mM 
NEM at 0°C for 30 min as described previously [20], and then were 
centrifuged at 20000 x g for 10 min. After washing three times with 
20 mM Tris-HCI (pH 8.0), 1 mM EDTA, and 1 mM DTT (TED), the 
membrane preparations were stored at -80°C. Before use, NEM- 
treated membranes were thawed, washed twice with 50 mM Tris-HCI 
(pH 8.0). and resuspended in TED (10 mg of protein/ml). For non- 
treated membranes, the membranes were prepared by the same pro- 
cedure except that 1 mM DTT was added to the membranes before 
the addition of 0.2 mM NEM. Protein in the membrane preparations 
was determined by the method of Lowry et al. [25]. 
Purified G proteins were incubated with NEM-treated membranes 
(about 7OOpg of protein) in TED at 0°C for 1 h in the presence of 
5 mM MgClz and 0.02% Lubrol PX in a total volume of 150~1. 
After incubation the mixture was diluted with TED (2.5 mg of pro- 
tein/ml) and used for the GABA binding assay. The u subunits of G 
proteins were preincubated with & subunits to form a trimer at 0°C 
for 15 min and then reconstituted with the membranes. 
2.3. CABA binding assay 
The binding of [3H]GABA was measured essentially as described 
previously [19]. In brief, 8021 (200 pg of protein) of the membrane 
suspension was incubated in 200 ,uI of 50 mM Tris-HCI (pH 7.5) con- 
taining 2.5 mM CaC12, 5 mM XigClz, 1 mM DTT. 50phl 
isoguvacine, and 10 nM [‘HIGABA in the presence or absence of 
100 PM ( ;fr )-baclofen for 10 min at 25°C. The final concentration of 
Lubrol PX wa, 0.0043% in assay mixture. The reaction mixture was 
then centrifuged at 20000 x g for 10 min and the pellet was rapidly 
and superficially rinsed with cold 50 ml\1 Tris-HCI (pH 8.0) and 
solubilized in Protosol (New England Nuclear) to be measured for 
radioactivity. Specific binding is defined as the difference between 
the total binding and the binding in the presence of 100 FM baclofen 
(the nonspecific binding). The nonspecific binding to NE%l-treated 
membranes was about 120 fmolimg protein either \vith or without G 
proteins. The difference obtained with G proteins was due to an in- 
crease in the total binding per mg protein. 
2.4. Other methods 
SDS-PAGE was carried out by the method of Laemmli [26]. 8 M 
urea/SDS-PAGE was performed by the method of Swanh and 
Munkres [27]. 
3. RESULTS 
NEM-treated membranes were incubated with 
various amounts of the purified G proteins for 1 h at 
0°C and analyzed for GABA binding (Fig. 2). The 
. 
reconstltutlon of G,, Gb or Gil markedly increased 
GABA binding to NEM-treated membranes in a dose- 
dependent manner. Because these three G proteins 
showed similar dose-dependent curves, they seemed to 
have similar ability to couple to GABAs receptors. The 
final protein concentration of membranes was about 
1 mg/ml in these experiments, and the concentration of 
endogenous G, determined by immunoassay [28] was 
about 75 pmol/mg protein, indicating that the effective 
concentrations of added G, were almost equivalent to 
its endogenous concentration. 
In contrast, the addition of the Gi2 purified from 
brain or lung slightly increased GABA binding to 
NEM-treated membranes (Fig. 2). When the effects by 
two Gil preparations were compared, brain Giz was ap- 
parently more effective than lung Gil in restoring 
GABA binding. However, this appeared to be due to 
the contamination of the brain Gil preparation with 
other G proteins including G,, because SDS-PAGE 
analysis of G proteins revealed the presence of a small 
amount of the protein with about 39 kDa in brain Giz 
preparation (Fig. 1). In addition, when the im- 
munoreactivity of G, was measured in Gil prepara- 
tions, it was equivalent to a 10070 amount of Gil in the 
brain preparation, while it was below 0.1% in the lung 
preparation. The increase of GABAa binding with 
500 pmol/ml of lung Gi2 was almost equal to that with 
15 pmol/ml of G,, G,* or Gil, indicating that the effect 
of Gi2 was 30-times less potent than the effects of the 
other G proteins. 
The G proteins used here were separated by DEAE- 
chromatography and were identified by their a 
subunits. The Py complexes had been usually con- 
sidered to be identical or very similar among these G 
proteins and were not well analyzed. The SDS-PAGE 
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Fig. 2. Effect of purified G proteins on [jH]GABA binding to NEM- 
treated membranes. NEM-treated membranes were incubated with 
various concentrations of the purified GTP-binding proteins as 
described in section 2. Binding assays were carried out with 10 nM 
[‘H]CABA. Concentrations of G proteins are shown as the final 
concentrations in binding assay with the values quantified by 
[35S]GTPyS binding. Protein concentration of membranes was 
1 mg/ml. Basal GABA binding (without G proteins) to NEM-treated 
membranes was 34 fmol/mg protein. The increase of GABA binding 
is shown as the binding with G proteins minus basal binding. Specific 
binding to nontreated membranes was 170 fmol/mg protein. G 
proteins were as follows: G, (a), Gt (0). G,r (o), brain G;z (A) and 
lung G,z (A). 
analysis (Fig. 1) revealed that each G protein contained 
both 36 kDa and 35 kDa,8 (36 kDa > 35 kDa), but G, 
and Giz contained more 35 kDa ,f3 than Gd and Gil, as 
shown by Goldsmith et al. [S]. Further analysis of their 
y subunits by urea/SDS-PAGE showed that brain G 








Fig. 3. 8 M urea/SDS-PAGE patterns of purified G proteins. 
Purified G proteins (1 pg) were subjected to urea/SDS-PAGE. The 
gel was stained with silver. Lane 1, G,; lane 2, GX; lane 3, G,r; lane 
4, brain G,z; lane 5, lung G,z; lane 6, IV, standards. Numbers on the 
right indicate molecular mass in kDa. 
Table I 
Increase of GABA binding to NEM-treated membranes by G, or G,z 
composed of different & complexes 
Addition Increase of GABA binding 
(fmol/mg protein) 
G& GI2ff 
None 5.2 0.0 
PY1 14.1 0.0 
R-2 41.6 0.6 
py-1/2a 46.8 0.5 
_ 
a A mixture of fly-1 and fly-2 
150 pmol/ml of CY subunits with or without equal molar of various 67 
subunit complexes were added to NEM-treated membranes and the 
increase of [‘H]GABA binding in the membranes was measured. 
Basal GABA binding (without G proteins) to NEM-treated 
membranes was 33 fmol/mg protein. Data are mean values from 3 
experiments 
tion to a major small y (y-2) [21] (Fig. 3). With regard 
to Gil , which hardly couple to GABAB receptors, both 
brain and lung Giz lacked y-l but lung Gi2 had another 
large y (Fig. 3). These results raised the question as to 
which subunit was crucial for the selective coupling to 
receptors. The cz subunits of G, and Gi2 were purified 
from bovine brain and lung, respectively, and two fly 
subunit complexes, fly-1 and fly-2, were isolated from 
bovine brain [21]. Both cy subunits were homogeneous 
on SDS-PAGE, as shown in Fig. 1. The fly-1 was com- 
posed of 36 kDa,8 and 6 kDa y and,&y-2 was composed 
of 36 kDa and 35 kDa /3 and 4.5 kDa y [21], and two 
y subunits probably had different primary structures 
[29]. Each a and fly subunit was mixed with a ratio of 
LY to fly of 1 : 1 to form G, or Gi2, and their abilities to 
increase GABA binding were determined by reconstitu- 
tion with NEM-treated membranes. As shown in Table 
I, the LY subunit alone of either G, and Gi2 caused a 
small or no effect on GABA binding. The ,f3y alone 
gave no effect (not shown). When the trimeric G pro- 
teins were reconstituted to NEM-treated membranes, 
GABA binding was markedly increased with G, com- 
posed of either /3y subunits, but not with Gi2 composed 
with eitherfly (Table I). These results indicated that the 
cr subunit was crucial for the selective coupling to 
receptors. However, Table I shows that the G, with 
,8y-2 was more effective than that with fly-1 in restoring 
GABA binding. The G, composed of the mixture of 
fly-1 and fly-2 was also very effective, and the increase 
in GABA binding was equal to that by the G, purified 
as a trimer form (Fig. 2). 
4. DISCUSSION 
In our previous paper, we showed that there was no 
selectivity for the coupling of ‘G,’ and ‘Gi’ to GABAB 
receptors [ 19,201. In these early studies, however, 
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purified ‘G,’ and ‘Gi’ were not strictly identified and 
might be a mixture of the G, or Gi family. Three 
subspecies of Gi were recently purified from brain or 
other tissues or cells [2-71, though Gi3 was not yet 
purified in an active form with enough amounts to use 
for experiments such as the reconstitution with recep- 
tors [6]. A novel form of C,, GW, was also identified 
[8]. In order to clarify the specificity of G proteins, we 
compared the ability of four G proteins, including G,, 
GZ, Gil and G,2 , to couple to GABAa receptors in this 
study. The reconstitution study showed that GABAR 
receptors coupled to purified G,, G,* and Gil, but hard- 
ly to Gi2. The inability of Gil to interact with receptors 
did not appear to be due to the inactivation, because 
the amounts of G proteins reconstituted were quan- 
tified with their ability to bind GTP+, and also 
because mastoparan stimulated the rate of the GTPyS 
binding to Gil as well as that to other G proteins (not 
shown). 
The selectivity of GABAB receptors for coupling to 
G proteins is quite different from that of D2 dopamine 
receptors [17], which coupled most efficiently to Gil 
but not to G,. However, G, is located predominantly 
in the nervous tissues and neuroendocrine cells, while 
Giz is located in all tissues [30,31]. In the brain, the 
level of G, was about 15-fold higher than that of Gi2, 
and the concentrations of Gi2 were constant throughout 
ontogenic development, while the G, levels markedly 
increased coincidently with neural development [3 11. 
These facts suggest that G, is involved in the 
neurotransmission and Gil in the fundamental process 
common to the various cellular functions rather than in 
neurotransmission. Our present results are in line with 
the aspect described above, and suggest that GABAB 
receptors selectively coupled to G, (and G,). 
The Gi2 preparation purified from bovine brain 
coupled to GABAe receptors better than the Gi2 
purified from bovine lung. However, this apparent in- 
consistency seemed to be due to the coupling of the 
contaminated G, to receptors. We obtained brain Gi2 
preparation by repeating rechromatography on Mono 
Q column, but it still contained G,. These observations 
suggest that the apparently low specificity of brain G 
proteins for coupling to receptors reported previously 
might be due to the contaminant of the preparation us- 
ed with other G proteins. The lung Gi2 preparation used 
in the present study contained little other G proteins, 
because the Gil is a major G protein in the lung [.5]. 
In the present study, G, and Gil displayed a similar 
efficacy to couple to GABAB receptors. However, it is 
likely that GABAn receptors separately regulate several 
effecters via G, and Gil, because the selectivity of G 
protein-effector coupling was also observed in various 
systems. It was reported that GABAR receptor agonist 
caused: (1) inhibition of Ca2+ channel [32,33]; (2) in- 
hibition of adenylyl cyclase [34]; (3) stimulation of K+ 
channel [35-371. First, with respect to Cal+ channel, 
234 
Hescheler et al. [38] reported that G, was clearly more 
effective than Gi for restoration of opioid inhibition of 
Ca2+ currents in NG 108-15 cells. In addition, an- 
tibodies to G,, but not those to Gi, antagonized 
noradrenalin-induced Ca’+ current inhibition in NG 
108-15 cells [39]. Therefore, GABAH receptors maybe 
regulate Ca’+ channel more efficiently via G, than via 
Gil-like neuropeptide Y receptors [40]. Second, ade- 
nylyl cyclase can be inhibited Lvith activated Gll~ but 
not with Goa and G,w [22]. Therefore, GABAB recep- 
tors may inhibit adenylyl cyclase via Gi, but it is still 
possible that G, inhibits this enzyme by its 37 subunits 
[41,42]. However, the third effector, the K+ channel, 
did not reveal selectivity for G protein when various LY 
subunits were reconstituted with the K+ channel from 
cardiac atria1 cells [ 1,431. These results suggest that G,I 
and/or G, mediate(s) the stimulation of K+ channel by 
GABAH receptors. 
The flu subunit complexes of purified G proteins 
were not identical and particularly those of Gi2 from 
both bovine brain and lung were different from other 
G proteins, suggesting a possible involvement of 30)~ to 
selective coupling of G proteins to GABAB receptors. 
Reconstitution of GABAB receptors to the G,a or Giza 
with various /3? complexes revealed that G,a could cou- 
ple to receptors with either ,Dy complexes but Gi2a 
could not with any fly complexes. Thus it is the cy 
subunit that determines the selective coupling to recep- 
tors. However, Gocv could couple to GABAH receptors 
with fly-2 more efficiently than with ,!3~-1, suggesting 
the ,#y complexes may also be involved in the selective 
coupling of receptors to G proteins. Since we previous- 
ly could not observe any difference between fly-1 and 
fly-2 except that only y-1 was phosphorylated by pro- 
tein kinase C [21], the present findings provide the first 
physiological difference between fly-1 and 67-2 com- 
plexes. 
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